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Abstract. Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV) possess similar structural and molecular
features, are transmitted by biting midges (genus Culicoides), and cause similar diseases in some susceptible ruminants.
Generally, BTV causes subclinical disease in cattle, characterized by a prolonged viremia. EHDV-associated disease in cattle is
less prominent; however, it has emerged as a major economic threat to the white-tailed deer (Odocoileus virginianus) industry
in many areas of the United States. The recent emergence of multiple BTV and EHDV serotypes previously undetected in the
United States demonstrates the need for robust detection of all known serotypes and differential diagnosis. For this purpose, a
streamlined workflow consisting of an automated nucleic acid purification and denaturation method and a multiplex one-step
reverse transcription quantitative polymerase chain reaction for the simultaneous detection of BTV serotypes 1–24 and EHDV
serotypes 1–7 was developed using previously published BTV and EHDV assays. The denaturation of double-stranded (ds)
BTV and EHDV RNA was incorporated into the automated nucleic acid purification process thus eliminating the commonly
used separate step of dsRNA denaturation. The performance of this workflow was compared with the World Organization
of Animal Health BTV reference laboratory (National Veterinary Services Laboratory, Ames, Iowa) workflow for BTV and
EHDV detection, and high agreement was observed. Implementation of the workflow in routine diagnostic testing enables
the detection of, and differentiation between, BTV and EHDV, and coinfections in bovine blood and cervine tissues, offering
significant benefits in terms of differential disease diagnosis, herd health monitoring, and regulated testing.
Key words: Bluetongue virus; Epizootic hemorrhagic disease virus; polymerase chain reaction.

Introduction
Bluetongue and epizootic hemorrhagic disease are hemorrhagic diseases of ruminants caused by Bluetongue virus
(BTV) and Epizootic hemorrhagic disease virus (EHDV),
respectively. Bluetongue virus and EHDV (family Reoviridae, subfamily Sedoreovirinae, genus Orbivirus) have segmented genomes composed of 10 segments of double-stranded
RNA that encode 7 structural and 4 nonstructural proteins.
The segmented viral genomes facilitate reassortment with
different serotypes during coinfection with other viruses of
the same species.30,46 Serotypes are determined by the viral
protein 2 (VP2), an outer capsid protein. To date, 26 serotypes of BTV and 7 serotypes of EHDV have been identified.4,10,20 Until 1998, only BTV serotypes 2, 10, 11, 13, and
17 were present in the United States. Since then, an additional 10 serotypes (1, 3, 5, 6, 9, 12, 14, 19, 22, and 24) have
been identified, primarily in the southern areas of the United
States.25 As for EHDV, 2 strains were endemic to the United
States (EHDV-1, New Jersey strain, and EHDV-2, Alberta

strain).12,34 However, in 2006, an exotic strain of EHDV-6
was isolated from white-tailed deer (Odocoileus virginianus)
in Indiana and Illinois.1 The virus has since been identified
throughout the midwestern, eastern, and southern United
States.1,2
Both BTV and EHDV are noncontagious viruses spread
by biting Culicoides midges. The viruses are endemic in geographical locations with temperate, subtropical, and tropical
climates (i.e., areas where the insect vector is present and
capable of spreading disease).20,30,46 Wild and domestic
ruminants, including sheep, cattle, and white-tailed deer are
susceptible to BTV and EHDV. Clinical disease from BTV
From the Texas A&M Veterinary Medical Diagnostic Laboratory,
College Station, TX (Schroeder, Meier, Bounpheng, Clavijo), and
the Diagnostic Virology Laboratory, National Veterinary Services
Laboratories, Ames, IA (Johnson, Ostlund).
1
Corresponding Author: Mangkey A. Bounpheng, Texas A&M
Veterinary Medical Diagnostic Laboratory, 1 Sippel Road, College Station,
TX 77843. mbounpheng@tvmdl.tamu.edu

This article is a U.S. government work, and is not subject to copyright in the United States.

710

Schroeder et al.

and/or EHDV infection is most often seen in white-tailed
deer and includes fever, excessive salivation and nasal discharge, and hemorrhaging from oral and nasal tissue.46 Serotypes of BTV found in the United States do not typically
cause clinical disease in cattle.25 However, exotic BTV serotypes are known to cause clinical signs, and occasionally
clinical signs are also seen with U.S. serotypes. In late summer through early fall of 2012, a significant number of epizootic hemorrhagic disease cases in cattle were confirmed in
the northern U.S. states of Nebraska, South Dakota, Wyoming, and Iowa, and it is believed that the disease was spread
from deer to cattle by insect vectors (Wilson D: 2013, Epizootic hemorrhagic disease update. Calif Vet Jan/Feb: 44–45).
In general, cattle most often act as reservoirs for BTV and
EHDV due to a prolonged cell-associated viremia, which
contributes significantly to the epidemiology of the disease.46
Bluetongue virus and EHDV infections can have a negative economic impact on the cattle and deer industry.19,30,41,46
The emergence of exotic strains of BTV and EHDV, as well
as the appearance of EHDV in cattle in northern states, demonstrates the emerging and dynamic nature of these viruses
and the potential increasing impact on the economy. Economic impact includes loss of infected animals, trade restrictions imposed on the movement of animals and/or livestock
and their products (i.e., semen and ova), and testing
costs.19,27,30 Because of the negative economic consequences
of BTV and EHDV infection, the World Organization for
Animal Health (OIE) has established recommendations for
international trade in order to prevent the spread of these
viruses to nonaffected countries.46
Several reverse transcription polymerase chain reaction
(RT-PCR) assays, targeting various viral proteins, have been
developed for the detection of BTV and EHDV.5,17,43,44
Because the viral genomes are composed of double-stranded
RNA (dsRNA), a denaturation step is included prior to
nucleic acid amplification. There are currently several methods in use for denaturation of the dsRNA genome, including
heat denaturation at 95°C (for 1–8 min) with or without
dimethyl sulfoxide15,40,41 and the use of various chemicals
such as methylmercury (II) hydroxide,3,45 trehalose,11,13,37
tetramethylene sulfoxide,11,13 and betaine.13,36 While these
methods are successful at enhancing amplification of BTV
and EHDV, they are labor intensive and create the potential
for contamination, as they require an additional step following nucleic acid purification and prior to PCR amplification.
In addition, several of the methods require the use of hazardous chemicals.
Therefore, an innovative streamlined workflow that
incorporates the denaturation of the viral dsRNA into the
nucleic acid purification was developed in order to eliminate
the separate step of dsRNA denaturation commonly used for
enhanced PCR sensitivity. The workflow consisted of an
automated nucleic acid purification and denaturation method
and a BTV and EHDV multiplex one-step quantitative RTPCR (mRT-qPCR) for the simultaneous detection of BTV

serotypes 1–24 (BTV serotypes 25–26 were not tested with
this workflow because these viruses were unavailable) and
EHDV serotypes 1–7. The performance of this workflow
was assessed by comparison with the OIE BTV reference
laboratory (http://www.oie.int/; the National Veterinary Services Laboratory [NVSL; Ames, Iowa]) workflow for detection of BTV and EHDV. Following successful performance
evaluation, the workflow was implemented at the Texas
A&M Veterinary Medical Diagnostic Laboratory (TVMDL;
College Station, Texas) for diagnostic testing of greater than
3,000 samples during a 1-year testing period.

Methods and materials
Virus reference strains
Viral stocks or BTV RNA of serotypes 1–24 were obtained
from the NVSL. Epizootic hemorrhagic disease virus serotypes 1 and 2 were obtained from the NVSL, while RNA for
EHDV serotypes 3–7 was kindly provided by the ArthropodBorne Animal Diseases Research Unit, Center for Grain and
Animal Health Research, Agricultural Research Service,
U.S. Department of Agriculture (Manhattan, Kansas).

Samples for performance evaluation
For the automated nucleic acid purification and RNA denaturation evaluation, the following samples were used: 20
BTV-only positive bovine blood samples, 37 (14 blood and
23 tissue) EHDV-only positive samples, and 33 (30 blood
and 3 tissue) BTV and EHDV–positive samples; positive
samples were defined by mRT-qPCR. For TVMDL workflow diagnostic sensitivity and specificity determination
using the NVSL workflow as the reference method, a total of
125 bovine blood samples (consisting of BTV, EHDV, and
BTV and EHDV positives and negatives) were used. Additionally, 126 BTV and EHDV–negative blood samples from
the presumed BTV and EHDV–free state of Wisconsin (confirmed by PCR by the Wisconsin Veterinary Diagnostic
Laboratory [WVDL; Madison, Wisconsin]) were used to
verify assay specificity.

TVMDL workflow
An in vitro transcribed BTV and EHDV control RNA, containing the target sequences for BTV and EHDV, and an in
vitro transcribed exogenous internal positive control (XIPC)
RNA were generated for mRT-qPCR optimization. DNA
sequences specific to BTV and EHDV, as well as XIPC,
were chemically synthesized and cloned into a plasmid vector by a commercial company.a Plasmids were linearized
using HindIII restriction enzyme digestion and subsequently
transcribed into RNA using a commercial transcription kit.b
In vitro transcription was performed according to the manufacturer’s instructions. In vitro transcripts were quantitated
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Table 1. Primers and probes for the Bluetongue virus and Epizootic hemorrhagic disease virus multiplex reverse transcription
polymerase chain reaction assays.*
Oligonucleotide

Amplicon
size (bp)

Sequence (5′–3′) and reporter dye

Bovine Bluetongue virus
BTVpan_Fprm_H TGGAYAAAGCGATGTCAAA
BTVpan_Rprm_H ACATCATCACGAAACGCTTC
BTVpan_pb
FAM-ARGCTGCATTCGCATCGTACGC-BHQ1
Epizootic hemorrhagic disease virus
EHD_F
ACWGGVATCATGTTTGAGCT
EHD_R
TTCATAACCGCACCTTCATC
EHD_pbI
VIC-TCATCACACATCGGC-MGB
EHD_pbII
VIC-TCTCGGCATATGCGAGC-MGB
Exogenous internal positive control
XIPC F
TTCGGCGTGTTATGCTAACTTC
XIPC R
CCACTGCGCCCAACCTT
XIPC pb
TAM-CTCCGCAGAAATCCAGGGTCATCG-BHQ2

Final 25-µl reaction
concentration (nM)

Target
region

Reference

96

450
450
100

NSP3

16

110

450
450
60
60

NSP1

14

69

200
200
125

NA

31

* FAM = 6-carboxyfluorescein; BHQ1, BHQ2 = black hole quencher 1 and 2, respectively; MGB = minor groove binder; NSP = nonstructural protein;
NA = not applicable.

using a spectrophotometer,c and sizes were verified by
electrophoresis.d
The TVMDL oligonucleotides sequence information and
the final reaction concentrations in the 25-µl mRT-qPCR are
provided in Table 1. Primer and probe sequences for detection of BTV, EHDV, and XIPC were adopted from previous
publications.14,16,31 The synthetic construct clone NISTag38
external RNA control sequence (GenBank accession no.
DQ883679) is a unique artificial antigenomic sequence with
no significant homology to annotated species sequences.
This sequence was used as the XIPC target. All primers and
probes were purchased from a commercial source.e
Nucleic acid was purified from all samples at TVMDL
using a commercial RNA isolation kit.b Briefly, a 50-µl
blood sample, or a 50-µl tissue homogenate (10% weight/
volume in 1× phosphate buffered saline), was transferred to
a 96-well, deep-well plate containing 20 µl of magnetic bead
mix (10 µl of lysis/binding enhancer and 10 µl of RNA binding beads), and 400 µl of lysis binding solution (containing
200 µl of lysis binding concentrate, 1 µl of carrier RNA [1
µg/µl], 1 µl of XIPC RNA [at 10,000 copies/µl] and 200 µl of
100% isopropanol) was added. This plate was denoted as the
sample plate. The following four 96-well plates were loaded
onto an automatic particle processorc for nucleic acid purification: sample plate, wash solution 1 plate (300 µl/well),
wash solution 2 plate (300 µl/well), and elution buffer plate
(90 µl/well). The nucleic acid purification procedure consisted of the following steps: lysis/binding for 5 min, one
60-sec wash 1, one 15-sec wash 2, 1-min dry step, and a
3-min heated elution step at 70°C or 95°C. For those samples
that were eluted at 70°C, all liquid was transferred to a PCR
plate, and then denatured at 95°C for 5 min on a thermal
cyclerf immediately following elution. All samples were
immediately placed on ice following denaturation.

The TVMDL mRT-qPCR utilized the components of a
commercial RT-PCR kitb (according to manufacturer’s
instructions) and the primers and probes for detection of BTV,
EHDV, and the XIPC; the final concentration of each oligonucleotide is provided in Table 1. Each reaction contained
12.5 µl of 2× multiplex RT-PCR buffer, 2.5 µl of 10× multiplex enzyme mix, 1 µl of 25× primer probe mix (containing all
the oligonucleotides in Table 1), 1 µl of nuclease-free water,
and 8 µl of nucleic acid template for a total volume of 25 µl.
The RT-qPCR was performed using a real-time PCR system.b
The cycling conditions were as follows: reverse transcription
at 48°C for 10 min (single cycle), activation/denaturation at
95°C for 10 min (single cycle), and 40 cycles of amplification
at 95°C for 15 sec and 55°C for 45 sec. For diagnostic sensitivity and specificity determination using the NVSL workflow as
the reference method, samples with a quantification cycle (Cq)
≤36.0 cycles were considered positive for BTV, while samples
with a Cq ≤40.0 cycles were considered positive for EHDV.

NVSL (OIE BTV reference laboratory)
workflow
The sequences of the oligonucleotides used in the nested PCR
(nPCR) are provided in Table 2. Primer sequences for detection of BTV and EHDV were obtained from previous publications.18,42 Nucleic acid was purified at the NVSL using a
commercial reagent per the manufacturer’s instructions.g
Each purified nucleic acid sample was resuspended in 25 µl
of RNase-free water, 5 µl was transferred to a PCR tube, and
the samples were heated at 95°C for 10 min on a thermal
cyclerb to denature the dsRNA. Samples were cooled at 4°C
prior to use in the RT-PCR.
The final concentrations (per reaction) of the oligonucleotides for BTV and EHDV in the RT-PCR and secondary
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Table 2. Primers for the Bluetongue virus and Epizootic hemorrhagic disease virus nested reverse transcription polymerase chain
assays.*
Oligonucleotide

Sequence (5′–3′)

Bluetongue virus
A (BT10)
GTTCTCTAGTTGGCAACCACC
B (BT283c)
AAGCCAGACTGTTTCCCGAT
C (BT169)
GCAGCATTTTGAGAGAGCGA
D (BT269c)
CCCGATCATACATTGCTTCCT
Epizootic hemorrhagic disease virus
A (EHD8)
AAGTTCTTCGTCGACTGCCATC
B (EHD449c)
GGTTGCACCATCTGGCCATAAT
C (EHD98)
AGCATTATCACCACAGTGGACG
D (EHD235c)
GCCAATCTATATGCCGCATGT

Amplicon
size (bp)

Final 50-µl reaction
concentration (nM)

Target
region

Reference

101

600–800
600–800
400–600
400–600

NSP1

18

138

600–800
600–800
600–800
600–800

NSP1

42

* NSP = nonstructural protein.

nPCR are provided in Table 2. Each RT-PCR reaction contained 27.0 µl of RNase-free water, 5.0 µl of 10× PCR buffer
(100 mM Tris–HCl, pH 8.3, 500 mM KCl),b 4.0 µl of 25 mM
MgCl2,b 4.0 µl of 10 mM deoxyribonucleotide triphosphate
(dNTP) mix,b 0.4 µl of RT enzyme (200 units/µl),g 0.125 µl
of RNase inhibitor (10 units/µl),g 0.5 µl of DNA polymerase
(5 units/µl),b and 4.0 µl of outer primers A and B (30–40
pmol of each primer for BTV or EHDV). Denatured template (5 µl) was mixed with 45 µl of the RT-PCR mixture and
amplified using a thermocycler.f The RT-PCR cycling conditions were as follows: 44°C for 50 min, 95°C for 10 min, 35
cycles of amplification at 95°C for 25 sec, 60°C for 20 sec,
and 72°C for 25 sec, with a final 5-min extension at 72°C,
followed by refrigeration. The secondary PCR reaction
(nPCR) contained 32.0 µl of RNase-free water, 5.0 µl of 10×
PCR buffer (100 mM Tris–HCl, pH 8.3, 500 mM KCl),b 3.5
µl of 25 mM MgCl2,b 4.5 µl of 10 mM dNTP mix,b 0.5 µl of
DNA polymerase (5 units/µl),b and 4.0 µl of nested primers
C and D (20–30 pmol of each primer for BTV or 30–40 pmol
of each primer for EHDV). The initial RT-PCR amplicon
(1.5 µl) was mixed with 48.5 µl of the nPCR mixture. The
cycling conditions for the nPCR were as follows: 95°C for
10 min (single cycle), 35 cycles of amplification at 95°C for
20 sec, 60°C for 20 sec, 72°C for 20 sec, with a final 5 min
hold at 72°C, followed by refrigeration.
Amplified PCR products were visualized on a 2.5–3%
agarose gel.h Amplified DNA products (8–10 µl) were mixed
with 3 µl of DNA loading buffer containing a DNA stain,i
loaded onto the gel, and run at 65–80 V for 1–1.5 hr. Bands
were visualized under ultraviolet light. All samples were
tested in duplicate, and only those samples containing bands
of the correct size (101 bp for BTV and 138 bp for EHDV)
for both duplicates were considered positive.

Statistical analysis
Regression analysis was performed using statistical softwarej to assess correlation between the automated RNA

denaturation and thermal cycler denaturation. Probit analysis was performed using statistical software j to assess the
limit of detection of each assay.8,9,35 Repeatability of the
mRT-qPCR was determined by calculation of the intra- and
interassay coefficient of variation (CV) for each pathogen
assay. Intra-assay variability was analyzed in triplicate
PCR at each dilution, and interassay variability was analyzed in 3 separate experiments (runs). Intra-assay CV =
[(average of each run’s Cq standard deviation (SD)/average
of each run’s Cq average) × 100]; interassay CV = [(SD of
the averages of each run/average of the averages of each
run) × 100].
Performance of the TVMDL workflow for the detection
of BTV and EHDV was evaluated by comparison against
the NVSL method using a panel of 125 positive and negative blood samples. Cohen’s kappa and percentage agreement were calculated using a previously published
method.24

Results
Automated 95°C denaturation versus separate
thermal cycler 95°C denaturation
The performance of the automated 95°C denaturation was
compared to the separate thermal cycler 95°C denaturation using 90 positive samples consisting of 20 BTVonly positive, 37 EHDV-only positive, and 33 BTV and
EHDV–positive samples. The automated 95°C denaturation produced equivalent or lower Cq values to the thermal cycler denaturation (Supplemental Fig. 1A, 1B). The
XY scatter plots of thermal cycler denaturation Cq values
versus the automated denaturation Cq values showed a
good correlation between the 2 denaturation methods
(Fig. 1A, 1B). Correlation coefficients for BTV and
EHDV were 0.9655 and 0.9438 (P values <0.0001 for
both), respectively, indicating that the 2 methods produced equivalent Cq values.
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Figure 1. Correlation of the automated 95°C denaturation versus the separate thermal cycler 95°C denaturation of Bluetongue virus
(BTV) and Epizootic hemorrhagic disease virus (EHDV) purified RNA. The XY scatter plots of the quantification cycle (Cq) values for the
thermal cycler denaturation versus the Cq values for the automated denaturation showed a good correlation between the 2 methods. A, BTV
assay; B, EHDV assay.

Intra- and interassay repeatability and
analytical sensitivity of BTV and EHDV assays
Triplicate mRT-qPCR assays in 3 separate experiments
were performed in order to assess the intra- and interassay
repeatability for the TVMDL BTV and EHDV assays as
well as the analytical sensitivity using probit analysis.
The CV within runs (intra-assay variability) ranged from
0.4% to 5.3% for BTV and 0.4% to 2.2% for EHDV;
between runs (interassay variability) ranged from 1.1% to
5.4% for BTV and 0.5% to 1.8% for EHDV (Supplemental Table 1). Serial dilutions of an in vitro transcribed
BTV and EHDV control RNA and XIPC RNA (1,000 copies/reaction) were used to estimate the analytical sensitivity of each assay. Probit analysis was performed for each
assay in order to determine the 95% mRT-qPCR detection
rate. The data sets for the last 5 purified nucleic acid dilutions of the intra- and interassay variability experiment
were used for the analysis. A total of 9 reactions
(responses) were used for each BTV- and EHDV-purified
nucleic acid dilution; Cq values below 40 were considered
a positive response or amplification. Copy number equivalents for the pathogen-purified nucleic acid dilutions
were estimated using the mRT-qPCR targeting serial dilutions of BTV and EHDV control RNA and subsequent
standard curve data analysis. The mRT-qPCR detection
limit was less than 200 BTV target copies and less than
100 EHDV target copies per PCR for both assays, as
determined by probit analysis. The probit graph (probability vs. log10 [dose] EHDV-purified nucleic acid) for
EHDV is displayed in Figure 2 (similar results were
obtained for BTV, data not shown).

Figure 2. Probit analysis of Epizootic hemorrhagic disease
virus (EHDV) detection by the multiplex reverse transcription
polymerase chain reaction assay. Serial dilutions of EHDV purified
nucleic acid were prepared in pathogen-negative bovine blood
nucleic acid and used for probit analysis. A total number of 9
responses for each nucleic acid dilution were analyzed in order to
determine the nucleic acid dilution corresponding to a detection rate
of 95%. Similar results were obtained for Bluetongue virus.

Analysis of diagnostic samples: comparison of
NVSL and TVMDL workflows
The performance of the TVMDL workflow was evaluated
for the detection of BTV and EHDV using a selection of 125
bovine blood samples submitted to the TVMDL. The samples were tested by the TVMDL and NVSL workflows. The
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Table 3. Performance comparison of the Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL; College Station, Texas)
and the National Veterinary Services Laboratory (NVSL; Ames, Iowa) workflows for the detection of Bluetongue virus (BTV) positive
only, Epizootic hemorrhagic disease virus (EHDV) positive only, and both BTV- and EHDV-positive samples.*
TVMDL
NSVL
BTV
Positive

Positive

Negative

Total

24

0

24

Negative
Total
EHDV
Positive

0
24

47
47

47
71

19

0

19

Negative
Total
BTV and EHDV
Positive

4
23

43
43

47
66

30

5

35

0
30

47
52

47
82

Negative
Total

Sensitivity (%)

Specificity (%)

Kappa

Agreement

100.0 (95%
100.0 (95%
CI: 0.86–1.00)
CI: 0.92–1.00)

1.00 (95% CI: 1.00–1.00; 1.00 (95%
almost perfect)
CI: 0.95–1.00)

100.0 (95%
91.0 (95%
CI: 0.82–1.00)
CI: 0.80–0.98)

0.86 (95% CI: 0.73–0.99; 0.94 (95%
almost perfect)
CI: 0.85–0.98)

86.0 (95%
100.0 (95%
CI: 0.70–0.95)
CI: 0.92–1.00)

0.87 (95% CI: 0.76–0.98; 0.94 (95%
almost perfect)
CI: 0.86–0.98)

* 95% CI = 95% confidence interval.

NVSL (OIE BTV reference laboratory) workflow was
selected as the reference method for diagnostic sensitivity
and specificity analysis (Table 3). The NVSL workflow
identified 24 (19%) BTV-only positives, 19 (15%) EHDVonly positives, 35 (28%) both BTV and EHDV positives, and
47 (38%) negatives (both BTV and EHDV).
The TVMDL workflow produced equivalent and reliable
results. The internal positive control, XIPC RNA, was
detected in all samples (average Cq = 31.8 ± 0.5), indicating
effective nucleic acid purification and amplification. For the
24 NVSL workflow BTV-only positives, the TVMDL workflow identified all 24 BTV positives (perfect agreement); 21
were identified as BTV-only positive and 3 as both BTV and
EHDV positive (EHDV Cq values = 33.5, 34.6, 38.8). For
the 19 NVSL workflow EHDV-only positives, the TVMDL
workflow identified all 19 positives (perfect agreement). For
the 35 NVSL workflow samples that were both BTV and
EHDV positive, the TVMDL workflow identified 30 as both
BTV and EHDV positive, 2 as BTV-only positive (with no
EHDV amplification, Cq values = 0), and 3 as EHDV-only
positive. For the 3 EHDV-only positives, BTV amplification
was positive with Cq values > 36.0 (Cq values = 39.7, 37.6,
37.2), which was greater than the Cq cutoff value established
for identification as BTV positive as determined based on
assay repeatability analysis. Thus, these samples were identified as BTV negative.
Lastly, for the 47 NVSL workflow negatives (both BTV
and EHDV), the TVMDL workflow identified 4 as EHDVonly positive (Cq values = 31.8, 32.4, 35.1, 37.0). The
TVMDL workflow agreement with the NVSL workflow
defined “positive” for BTV-only positives was 100% (κ =
1.00, almost perfect), for EHDV-only positives was 94%

(κ = 0.86, almost perfect), and both BTV and EHDV positives was 94% (κ = 0.87, almost perfect; Table 3). The agreement for identification of all BTV positives and all EHDV
positives, irrespective of single pathogen or dual pathogen
positive classification, was calculated to be 98% (κ = 0.95,
almost perfect) and 93% (κ = 0.85, almost perfect), respectively (Table 4). This same sample panel was also tested with
singleplex BTV or EHDV RT-qPCR, and comparable results
with mRT-qPCR were obtained (data not shown) supporting
the use of the mRT-qPCR assay. For additional workflow
specificity assessment, 126 BTV and EHDV–negative blood
samples from the presumed BTV and EHDV–free state of
Wisconsin (samples were confirmed negative by PCR by
WVDL) were tested and confirmed to be negative using the
TVMDL workflow.

Analysis of TVMDL diagnostic samples
On completion of the successful performance evaluation
study, the TVMDL workflow was implemented for routine
testing of diagnostic samples submitted to the laboratory for
regulatory requirements, herd health management, and
clinical diagnosis. Over the course of 1 year (December
2011–December 2012), approximately 3,043 samples consisting of bovine, ovine, caprine, and cervine specimens (i.e.,
blood, tissue, and semen) were tested as diagnostic submissions (Table 5). A total of 376 positives (approximately
12.4% positive rate) were identified; specifically, 157 BTVonly positives (5.2% positive rate), 176 EHDV-only positives (5.8%), and 43 both BTV and EHDV positives (1.2%).
Bluetongue virus and EHDV coinfections were observed at
an 11.4% rate (of all positives, 43/376).
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Table 4. Performance comparison of the Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL; College Station, Texas)
and the National Veterinary Services Laboratory (NVSL; Ames, Iowa) workflows for the detection of all Bluetongue virus (BTV)–positive
samples and all Epizootic hemorrhagic disease virus (EHDV)–positive samples, irrespective of single pathogen or dual pathogen positive
classification.*
TVMDL
NVSL

Positive

Negative

Total

Sensitivity (%)

Specificity (%)

Kappa

Agreement

56

3

59

95.0 (95%
CI: 0.86–0.99)

100.0 (95%
CI: 0.95–1.00)

0.95 (95% CI: 0.90–1.00;
almost perfect)

0.98 (95%
CI: 0.93–1.00)

Negative
Total
EHDV
Positive

0
56

66
69

66
125

52

2

54

96.0 (95%
CI: 0.87–1.00)

90.0 (95%
CI: 0.81–0.96)

0.85 (95% CI: 0.76–0.95;
almost perfect)

0.93 (95%
CI: 0.87–0.97)

Negative
Total

7
59

64
66

71
125

BTV
Positive

* 95% CI = 95% confidence interval.

Table 5. Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV) diagnostic submissions and outcomes over a
1-year period (n = 3,043 samples total).
No. of submissions

BTV-only positive

EHDV-only positive

BTV and EHDV
positive

Species

Blood

Semen

Tissue

Blood

Tissue

Blood

Tissue

Blood

Tissue

Bovine
Caprine
Cervine
Ovine
Unknown
Total

1,812
24
73
47
29
1,985

453
0
0
0
1
454

20
34
542
6
2
604

103
1
1
0
2
107

0
1
47
2
0
50

36
0
18
1
1
56

0
14
106
0
0
120

34
0
0
0
0
34

0
0
9
0
0
9

Of the 157 BTV-only positives, 103 were from bovine
blood, 48 were from cervine tissues, and the remaining 6
were from ovine, caprine, or unknown sources; the cervine
positive tissues consisted of mainly spleen (32/48, approximately 67%), while other tissues such as tonsil, lung, testes,
and lymph node represented a minor set of positive tissue
samples. Limited clinical hemorrhagic disease information
was provided in the submissions thus correlation of infection
with disease was not possible. However, it is interesting to
note that of the BTV-only positive samples, 2 bovine blood
samples and 37 cervine tissue samples (approximately 77%
of 48 BTV-only cervine tissue positives) were from animals
with clinical hemorrhagic disease; the remaining 112 samples (101 bovine and 11 cervine) lacked clinical disease
information.
Of the 176 EHDV-only positives, 124 were from cervine
blood (n = 18) and tissue (n = 106), 36 were from bovine
blood, and the remaining 16 were from caprine tissue (n =
14), ovine (n = 1), or unknown sources (n = 1). The majority
of positive tissue samples (96/120, 80%) were spleen, similar

to the BTV positive tissues. All 36 bovine samples and 41
cervine samples lacked clinical disease information. However, 83 of the 124 total cervine EHDV-only positives
(approximately 67%) were from animals with clinical disease
Interestingly, of the 43 both BTV and EHDV–positive
samples identified, 34 were from bovine blood samples. Two
of these 34 coinfected bovine samples were from animals
with clinical signs; both animals were from farms reporting a
BTV and/or EHDV outbreak; the remaining 32 samples
lacked disease information. The other 9 BTV and EHDV
copositive samples were from cervine tissues (spleen, testes,
tonsil, and salivary gland), 5 of which were from animals with
disease, while 4 were samples submitted without disease
information. Neither BTV nor EHDV was detected in any of
the semen (n = 454) samples submitted for diagnostic testing.

Discussion
Bluetongue virus and EHDV are 2 viral diseases of economic
importance to the cattle and white-tailed deer industry in the
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United States.19,41,46 Identification of these viruses is important in order to evaluate their distribution and epidemiology.
The current available reference laboratory PCR method for
the detection of BTV and EHDV involves 2 separate nPCR
reactions, 1 for each virus.46 Additionally, in order to enhance
sensitivity, the purified double-stranded viral RNA is denatured in a separate step following nucleic acid purification
and prior to PCR amplification.13,27,40 The dsRNA denaturation step, however, is time consuming, requires the use of
hazardous chemicals, and can create the potential for contamination and human error due to additional pipetting steps.
In order to reduce potential errors and possible contamination from these additional pipetting steps, an innovative
streamlined workflow was developed for the rapid denaturation and subsequent detection of BTV (serotypes 1–24) and
EHDV (serotypes 1–7). Denaturation (95°C for 3 min) of the
viral dsRNA was incorporated into the elution step of the
automated particle processorc program. Therefore, the viral
nucleic acid was denatured during nucleic acid purification,
thus eliminating the need for a separate denaturation step
prior to RT-qPCR amplification.
Comparison of the automated 95°C denaturation method
and the commonly used separate thermal cycler 95°C denaturation step method demonstrated that the automated denaturation method produced equivalent or lower Cq results for
the detection of BTV and EHDV. Correlation coefficients of
0.9655 and 0.9438 (P values <0.0001 for both) for BTV and
EHDV, respectively, revealed a strong correlation between
both denaturation methods.
The streamlined workflow presented herein, consisting of
automated denaturation and purification followed by BTV
and EHDV mRT-qPCR amplification, was assessed against
the thermal cycler denaturation and nPCR workflow performed at the NVSL, an OIE BTV reference laboratory.
When compared with the NVSL workflow, the TVMDL
workflow showed a diagnostic sensitivity of 95.0% for BTV
positives and 96% for EHDV positives, and a diagnostic
specificity of 100.0% for BTV-positive and 90.0% for
EHDV-positive samples, respectively, irrespective of single
pathogen or dual pathogen positive classification. Overall,
the results demonstrate very good agreement between the 2
workflows and greater than 95% sensitivity for the TVMDL
workflow, thus providing support for the applied utility of
this method for BTV and EHDV detection. Practical advantages of the TVMDL workflow include dsRNA denaturation
during the automated nucleic acid purification elution step,
inclusion of an internal positive control for nucleic acid purification and detection, and concurrent detection and analysis
of BTV and EHDV in a single reaction, which reduces testing costs. In addition, inclusion of the internal control reduces
the potential of reporting false-negative results due to system
and human error, thus providing more confidence in the
results. The described automated nucleic acid purification
method is also the universal pathogen nucleic acid purification method that is used for diverse biological samples that are

submitted for testing at TVMDL, thus enabling sample batching and minimizing labor, equipment, and consumables usage.
The utility of this workflow was demonstrated in the routine diagnostic testing of approximately 3,043 samples submitted to TVMDL during a 1-year period. Of the 376 positive
samples identified, 41% (157/376) were BTV-only positives,
47% (176/376) were EHDV-only positives, and, interestingly, 11.4% (43/376) were both BTV and EHDV–positive
coinfections.
There have been several reports in the literature of natural
BTV and EHDV coinfections, multiple BTV serotype coinfections, and BTV or EHDV reassortants in both cattle and
sheep,28,39,42 as well as in the insect vector.29 Multiple reports
from India have detected BTV reassortments in sheep
between BTV-16 and BTV-21,32 BTV-3 eastern and western,21 BTV-2 eastern and western,22 and BTV-23 eastern and
western topotypes.23 In the United States, a BTV reassortant
that included genes from BTV-2 and BTV-6 was reported in
a cow with BTV clinical disease.26 Epizootic hemorrhagic
disease virus reassortants, such as an EHDV-6 (Indiana) that
contained genes from endemic EHDV-2 (Alberta) and exotic
EHDV-6 (Australia) serotypes, was first recovered from
dead white-tailed deer in Indiana and Illinois in 2006.1 In
addition to reassortants, dual BTV serotype coinfections
have also been reported: BTV-1 and BTV-12, BTV-3 and
BTV-24, and BTV-22 and BTV-24, in several cattle with no
clinical signs of disease in Kenya,39 and BTV-4 and BTV-16,
and BTV-4 and BTV-24 in 2 different cows, respectively,
with BTV clinical signs in Israel.7 Because several of these
reports identified multiple BTV serotype coinfections in animals with and without clinical signs, the significance of BTV
serotype coinfections in disease manifestation is currently
unclear. Other factors such as breed and age may play a role
in disease presentation. Several of the reports7,39,46 do, however, speculate that these reassortants may be more virulent
than the parental serotypes and may therefore be responsible
for the increased virulence observed in diseased animals.
However, additional studies are needed to verify this assumption.
With regard to BTV and EHDV coinfections, an investigation of the Reunion Island cattle population consisting of
116 cows exhibiting BTV and EHDV clinical signs reported
a 4% (5/116 total blood samples tested) BTV-2–EHDV-6
coinfection rate.28 Because 91% of this cattle population
were EHDV-6–only positive, and the coinfected cattle were
infected with BTV-2, which, according to the authors, has
never caused clinical signs, the authors speculate that the
clinical signs displayed in the BTV-2 and EHDV-6 coinfected cattle may be a result of EHDV-6. In this report,28
BTV-only infections were not detected. Another report identified a 58.6% coinfection rate (58/99 total cow blood samples tested) in nondiseased cows in Kenya.39 In the current
study, BTV and EHDV coinfections were identified in cattle
at a rate of 1.49% (34/2,285 total bovine samples tested), and
in white-tailed deer (cervine) at a rate of 1.46% (9/615 total
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cervine samples tested). Two of the 34 coinfected cattle
exhibited clinical disease and were from farms reporting a
BTV and/or EHDV outbreak; 5 of 9 coinfected white-tailed
deer exhibited clinical disease; and the remaining coinfected
samples lacked disease information, thus disease correlation
with these coinfections is unknown. Based on the available
published literature, the current study has evaluated the highest number of animals for BTV and EHDV coinfections thus
far in a U.S. sampled population. The importance of these
coinfections in the transmission and virulence of these
viruses is currently unknown, as there are neither reports of
reassortment events between BTV and EHDV, nor reports of
exacerbated clinical disease with coinfections. Nevertheless,
these coinfections may be important in understanding disease presentations. Similarly, coinfections among multiple
BTV serotypes or multiple EHDV serotypes may be important in virus transmission as they create opportunities for
potential interaction between several BTV or EHDV serotypes that can potentially result in the generation of newer,
more virulent BTV or EHDV serotypes.6,33,38 The potential
emergence of new virulent serotypes or the invasion of serotypes previously unseen in certain geographic locations
therefore emphasizes the need for rapid identification and
differentiation of these 2 viruses that present similar clinical
signs.
In summary, a streamlined workflow that includes an
innovative automated dsRNA denaturation during nucleic
acid purification, followed by the simultaneous detection of
BTV and EHDV by mRT-qPCR, has been developed. This
workflow provides rapid, reliable results, and reduces the
potential for contamination and human error by eliminating
the separate denaturation step commonly used to denature
BTV and EHDV dsRNA. Implementation and ongoing use
of this workflow has enabled detection of single and dual
infections in diverse samples for regulatory testing, herd
health management, and differential disease diagnosis. The
simultaneous and differential detection of BTV and EHDV
provides significant benefits for 2 important ruminant diseases with similar clinical presentations, particularly in light
of reports of BTV- and EHDV-associated clinical disease in
cattle.
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Supplemental Figure 1. Automated 95°C denaturation versus the separate thermal cycler 95°C
denaturation of Bluetongue virus (BTV) and Epizootic hemorrhagic disease virus (EHDV)
purified RNA. BTV- and/or EHDV-positive samples (90 total; 20 bovine blood BTV-positive
only, 37 EHDV-positive only [(14 blood, 23 tissue)], and 33 BTV and EHDV [(30 blood, 3
tissue)]) were purified and detected using the Texas A&M Veterinary Medical Diagnostic
Laboratory (TVMDL) workflow, which consisted of an automated nucleic acid purification and
then a multiplex reverse transcription quantitative polymerase chain reaction (mRT-qPCR)
assay. Samples were either denatured at 95°C during the automated elution step, immediately
denatured at 95°C for 5 min on a thermal cycler following nucleic acid purification, or not
denatured following nucleic acid purification and tested by mRT-qPCR. A, BTV assay; B,
EHDV assay. Cq = quantitation cycle.

